Carregant...
Targeting Leukemia Stem Cell-Niche Dynamics: A New Challenge in AML Treatment
One of the most urgent needs in AML is to improve the disease cure rate as relapse still occurs in 60–80% of patients. Recent evidence suggests that dismal clinical outcomes may be improved by a better definition of the tight interaction between the AML cell population and the bone marrow (BM) micro...
Guardat en:
| Publicat a: | J Oncol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Hindawi
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6702816/ https://ncbi.nlm.nih.gov/pubmed/31485227 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/8323592 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|